Information and education only. Every page, figure and calculator on this site exists to explain how financial instruments work. Nothing here is investment, tax or legal advice, a recommendation, or a valuation you can rely on. Full disclaimer

The ABN AMRO Break-up, 2007Medium

A bank bought in cash by a consortium at the top of a cycle, with the pieces divided in advance — and the capital paid out just before it was needed.

3 min read · 516 words

What happened

  • March 2007 — a Dutch bank is in discussions with a UK bank about an agreed combination in shares.
  • April 2007 — a consortium of three European banks assembles a competing offer, mostly in cash, and higher. Each member is to take specified parts of the target.
  • October 2007 — the consortium offer prevails and completes, as the largest banking transaction of its time, paid overwhelmingly in cash.
  • Within a year — the wholesale funding markets tighten severely; one consortium member reports very large losses and receives a UK government recapitalisation in October 2008.
  • The Dutch parts are taken into state ownership by the Netherlands in October 2008.

The mechanism

  • Cash consideration takes the buyer's shareholders out of the decision. In a share deal they vote on issuing the currency; in a cash deal of this shape they frequently do not, and the balance-sheet effect lands on them anyway.
  • A consortium bid is several acquisitions in one offer. The separation of the target is agreed before completion, which raises the price a seller can achieve and multiplies the execution risk after it.
  • The price was paid in capital. Cash for a bank acquisition is regulatory capital leaving the buyer's balance sheet at the moment it is committed, not when the accounts are prepared.
  • Due diligence on the target was limited in the contested phase, which is a structural feature of a hostile or competitive situation rather than an oversight — see what kills a deal on the diligence blocker.
  • Nothing here required the transaction to be wrong to be dangerous. The same purchase funded in shares would have left a different capital position facing the same year.

What it teaches

  • Ask what the consideration does to the buyer's balance sheet, not only what it does to earnings per share. A deal can be accretive and still leave the acquirer thinner.
  • Competitive tension raises the price and lowers the information. Both move together, and a seller running a process is buying the first with the second.
  • A consortium multiplies the post-completion risk: three integrations, three sets of assumptions, one signature.
  • Timing is a risk nobody underwrites. The cycle is not a diligence item, and a transaction agreed in one funding environment completes in whichever one arrives.

The mechanisms behind this

Every case on this site is an instrument or a mechanism doing exactly what it was built to do, in a situation nobody had pictured. These are the pages that explain the machinery:

Information and education only. This is a simplified summary of publicly reported events, written for teaching purposes. It compresses a complex episode, omits material detail, and does not characterise the conduct or motives of any person or organisation. It is not advice, not a forecast, and not a recommendation about any market, instrument or institution.